BBH News and Press, VanEck Vectors Biotech ETF

2026-03-08 14:42:00 ET Transcript Oscar Pulido: American consumers remain one of the most important signals for the US economy. For the last few years, they've repeatedly defied expectations, continuing to spend despite higher inflation and higher interest rates.... Re...

2026-03-06 04:00:00 ET By Christian Floro, CFA, CMT Market Strategist ... Read the full article on Seeking Alpha For further details see: The Trump Administration's Affordability Plan

2026-03-02 13:04:23 ET More on the markets The Next Bust Could Be On The Horizon Cross-Asset Vols Spike On Iran Risk As Oil Surges SPY: The Market Has Entered A Wait-And-See Phase Stocks make a U-turn into the green amid U.S.-Israel-Iran conflict escalation ...

2026-02-26 06:56:00 ET Optimism builds as positioning evolves Equity managers are navigating a challenging backdrop: concentrated market leadership, wide valuation gaps between U.S. and non-U.S. equities, and policy uncertainty as we move through Q1 2026. AI positioning remains ...

2026-02-19 16:36:07 ET More on the markets 4 Ways Market Dynamics Are Changing In 2026 AAII Sentiment Survey: Neutral Sentiment Leaps Dow Jones And U.S. Index Outlook - The Costs Of Hesitation SA Analyst: Energy strengthens, and industrial dip-buying reinforc...

2026-02-18 22:38:10 ET Since my last article in August, "Incyte: Wall Street Underestimates Strength of Ruxolitinib Portfolio," Incyte shares ( INCY ) are up 19.1%.... Read the full article on Seeking Alpha For further details see: Incyte Remains Undervalued As O...

2026-02-13 14:01:58 ET More on pharmaceuticals, biotech Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More BBH: Mature Biotech Exposure, But Limited Growth Ahead XPH: Healthcare Dashboard For January Most and least shorted m...

2026-02-07 01:50:00 ET ... Read the full article on Seeking Alpha For further details see: How AI Is Reshaping Drug Discovery And Healthcare Investing

2026-01-28 23:50:00 ET After the run higher in valuations, investors may want to consider smaller, mid-cap stocks for both portfolio diversification and growth potential, according to Brian Dasuch, Portfolio Specialist with T. Rowe Price. ... Read the full article on Seeking A...

2026-01-22 13:04:02 ET More on Novartis Novartis AG (NVS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Novartis AG (NVS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Novartis: A Mispriced Hedge In A Crowded Equity Mark...